ProteXase Therapeutics
Focused on the rational drug discovery and development of sHAIs as a more effective treatment option for lung and colon cancer patients, including those which are resistant to current therapies
Metro International Biotech
A privately-owned clinical-stage pharmaceutical company that has established the most comprehensive portfolio of proprietary NAD+ precursors in the world
Kalocyte
Develops ErythroMer, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply
InvivoSciences
A precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues
Integro Theranostics
A startup with the potential to revolutionize cancer treatment and is committed to improving outcomes for all patients
Hillmed
Develops diagnostic and therapeutic treatment devices for pelvic floor pain
Fimbrion Therapeutics
Develops drugs for the prevention and treatment of infectious diseases caused by bacteria, including drug-resistant strains
Fertilplus Partners
A biotechnology company developing fertility drugs in the horse breeding industry
Cellatrix
Developed patient-derived 3D culture system to recapitulate the complex biology of bone marrow microenvironment
C2N Diagnostics
Novel diagnostics and therapies for Alzheimer’s disease